Siegfried Holding AG
Siegfried Holding AG
- Market cap
- $4.58B
- P/E ratio
- 16.68
Your view on SGFEF
Overview
What the company does, where it operates, and who runs it.
About Siegfried Holding AG
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Marcel Imwinkelried
- Headquarters
- Untere Bruehlstrasse 4, Zofingen, CH
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Marcel Imwinkelried
- Headquarters
- Untere Bruehlstrasse 4, Zofingen, CH
Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products.
It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production.
In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products.
The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Siegfried Holding AG. Starting points for Siegfried Holding AG: P/E 16.7, EPS $3.90, beta 0.80 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Siegfried Holding AG. Siegfried Holding AG does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Siegfried Holding AG. Trailing twelve-month EPS for Siegfried Holding AG stands at $3.90. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Buy
Analyst ratings
4 ratings- Strong Buy0
- Buy2
- Hold2
- Sell0
- Strong Sell0
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterJun 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | CHF 2.39 | CHF 1.61 | CHF 3.84 | CHF 4.36 |
| Lowest estimate | CHF 2.38 | CHF 1.61 | CHF 3.74 | CHF 4.25 |
| Highest estimate | CHF 2.40 | CHF 1.61 | CHF 4.01 | CHF 4.56 |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | CHF 2.21 | CHF 1.89 | CHF 3.85 | — |
| Growth vs a year ago | +8.1% | −14.9% | −0.4% | — |
Revenue estimates
| Total | This quarterDec 2026 | Next quarterJun 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | CHF 752.38M | CHF 635.95M | CHF 1.35B | CHF 1.47B |
| Lowest estimate | CHF 752.38M | CHF 635.95M | CHF 1.34B | CHF 1.43B |
| Highest estimate | CHF 752.38M | CHF 635.95M | CHF 1.37B | CHF 1.56B |
| Number of analysts | 1 | 1 | 11 | 12 |
| A year ago | CHF 674.67M | CHF 619.52M | CHF 1.33B | — |
| Growth vs a year ago | +11.5% | +2.7% | +1.8% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Siegfried Holding AG. Siegfried Holding AG has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| ESAIYEisai Co., Ltd. | Healthcare | OTC | $9.4B | ||
| ESALFEisai Co., Ltd. | Healthcare | OTC | $9.3B | ||
| ETONEton Pharmaceuticals, Inc. | Healthcare | NASDAQ | $1.8B | ||
| ETSTEarth Science Tech, Inc. | Healthcare | OTC | $32.3M | ||
| EVIOEVIO, Inc. | Healthcare | OTC | $1.9M | ||
| EVOEvotec SE | Healthcare | NASDAQ | $468.8M | ||
| EVOTFEvotec SE | Healthcare | OTC | $1.4B | ||
| EVRRFMolecule Holdings Inc. | Healthcare | OTC | $626,130 | ||
| EWPIEmerging World Pharma, Inc. | Healthcare | OTC | $11,930 | ||
| EXL.AXElixinol Wellness Limited | Healthcare | ASX | — | ||
| EXMTAnything Technologies Media, Inc. | Healthcare | OTC | $2.4M | ||
| FFNTF4Front Ventures Corp. | Healthcare | OTC | $62,300 | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Siegfried Holding AG.